|
Real-time Estimate
Cboe BZX
19:33:35 09/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 19.31 USD | -0.72% |
|
-9.66% | +25.29% |
| 09-04 | Climb Bio's Phase-1 Data From IgA Nephropathy Trial 'Positive,' Wedbush Says | MT |
| 08-10 | Wedbush Adjusts Price Target on Jade Biosciences to $47 From $45, Keeps Outperform Rating | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.72% | -9.66% | -11.03% | +27.02% | +25.29% | +153.71% | - | - | - | 1.24B | |
| -3.24% | -7.78% | -7.18% | +8.62% | +0.04% | -5.35% | +10.43% | -30.27% | +194.79% | 48.01B | |
| +1.12% | +0.19% | +1.29% | +40.17% | +163.19% | +412.04% | +537.75% | +586.19% | - | 44.44B | |
| -1.40% | -3.19% | +5.55% | +37.14% | +13.32% | +34.69% | +18.62% | -2.24% | +231.43% | 42.67B | |
| -0.69% | -3.50% | -2.75% | +30.18% | +14.91% | -0.57% | +66.85% | +3.49% | +1,052.96% | 39.96B | |
| 0.00% | -2.61% | -8.13% | +14.87% | +6.22% | +13.09% | +42.33% | -18.57% | +139.05% | 32.75B | |
| -2.38% | -1.51% | +2.99% | +23.47% | - | - | - | - | - | 17.74B | |
| -2.15% | -2.19% | -3.72% | +24.26% | +3.27% | +19.45% | +107.63% | +200.23% | +1,862.84% | 16.49B | |
| -0.37% | -2.53% | +1.28% | +9.17% | +13.69% | +10.91% | +30.93% | -42.85% | +88.27% | 14.38B | |
| -0.91% | -4.75% | +0.32% | +46.37% | +39.31% | +76.57% | +39.18% | -37.27% | +252.83% | 13.4B | |
| +0.87% | +0.41% | -3.34% | +5.72% | -11.92% | -5.00% | -37.17% | -38.02% | +113.60% | 12.22B | |
| -3.15% | +0.43% | +12.98% | +27.42% | +5.34% | -23.21% | - | - | - | 11.6B | |
| -0.03% | -0.02% | +0.23% | +32.85% | +22.91% | +33.37% | +0.91% | -43.10% | +172.47% | 11.34B | |
| -2.50% | -2.14% | -7.93% | +88.56% | +46.64% | +27.88% | +54.18% | -50.20% | - | 10.74B | |
| +0.20% | +4.71% | -8.91% | +17.95% | -15.95% | +32.46% | +505.26% | +182.29% | +2,449.12% | 10.24B | |
| -0.80% | -2.37% | -4.88% | +39.43% | +18.42% | +771.95% | +1,717.92% | +15.31% | - | 9.84B | |
| -0.76% | -2.60% | +6.41% | +50.23% | +48.49% | +165.73% | +505.56% | +80.05% | - | 9.68B | |
| -0.83% | -8.98% | -1.97% | -25.15% | -29.44% | -13.32% | +35.19% | +53.94% | +92.42% | 9.42B | |
| -0.75% | -0.96% | -3.55% | +36.66% | +65.65% | +147.91% | +667.13% | +215.76% | +1,066.77% | 9.44B | |
| +0.21% | -3.82% | -3.05% | +12.61% | -10.19% | -14.14% | -10.28% | -31.40% | +40.63% | 8.76B | |
| Average | -0.91% | -1.08% | -1.77% | +27.38% | +22.06% | +96.75% | +252.50% | +61.37% | +596.71% | 18.72B | |
| Weighted average by Cap. | -0.94% | -1.05% | -1.48% | +26.90% | +30.42% | +91.59% | +190.96% | +86.65% | +523.85% |
- Stock Market
- Stocks
- JBIO Stock
- Sector Jade Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
